Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nonlinear Pharmacokinetics: Michaelis-Menten Equation01:18

Nonlinear Pharmacokinetics: Michaelis-Menten Equation

990
The Michaelis–Menten equation is a fundamental model for describing capacity-limited kinetics in drug metabolism. It offers insights into the rate of decline of plasma drug concentration Cp over time, with Vmax and KM as pivotal parameters.
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
990
Enzyme Inhibition01:30

Enzyme Inhibition

91.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.3K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K
Determination of Michaelis Constant and Maximum Elimination Rate01:20

Determination of Michaelis Constant and Maximum Elimination Rate

409
The Michaelis constant (KM) and the theoretical maximum process rate (Vmax) are vital parameters in the Michaelis-Menten equation, central to many biochemical reactions. They provide essential insights into enzyme kinetics and drug metabolism.
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
409
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

6.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.3K
Feedback Inhibition00:46

Feedback Inhibition

56.8K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Hybrid Experimental and in silico Platform for ITPK1 Chemical Probe Discovery.

SLAS discovery : advancing life sciences R & D·2026
Same author

Phosphoinositides and inositol phosphates as molecular glues.

FEBS letters·2026
Same author

Structure-guided compound prioritization strategy for virtual screening identifies putative binders for the nuclear receptor LRH-1.

bioRxiv : the preprint server for biology·2026
Same author

Structural insights into the development of inhibitors for inositol phosphate kinases.

FEBS letters·2026
Same author

Proteomic Analysis Provides Insights Into PPIP5K2 Function and Its Impact on Corneal Energy Metabolism.

Investigative ophthalmology & visual science·2026
Same author

VisMoDAI: Visual Analytics for Evaluating and Improving Corruption Robustness of Vision-Language Models.

IEEE transactions on visualization and computer graphics·2025
Same journal

A human-specific genetic modifier reconfigures large-scale cortical network dynamics underlying behavioral performance.

bioRxiv : the preprint server for biology·2026
Same journal

<i>Staphylococcus aureus</i> uses a eukaryotic-like uridyltransferase to make UDP-GlcNAc for cell wall synthesis.

bioRxiv : the preprint server for biology·2026
Same journal

Dynamic redistribution of eIF4F controls cap-dependent translation initiation.

bioRxiv : the preprint server for biology·2026
Same journal

When does additional information improve accuracy of RNA secondary structure prediction?

bioRxiv : the preprint server for biology·2026
Same journal

Normative brain-state trajectories reveal deviation from healthy aging in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same journal

Noradrenergic infraslow rhythm during sleep is the critical link between heart-rate dynamics and memory consolidation.

bioRxiv : the preprint server for biology·2026
See all related articles

Related Experiment Video

Updated: Jan 10, 2026

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors
09:11

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Published on: November 23, 2019

7.1K

Structural rationalization of IPMK inhibitor potency.

Huanchen Wang, Stephen B Shears, Raymond D Blind

    Biorxiv : the Preprint Server for Biology
    |November 24, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Structural insights into potent inositol polyphosphate multikinase (IPMK) inhibitors reveal a key binding pocket and ordered waters, guiding future cancer drug development.

    More Related Videos

    Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
    10:33

    Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

    Published on: October 26, 2015

    11.8K
    Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
    08:49

    Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

    Published on: January 22, 2019

    9.5K

    Related Experiment Videos

    Last Updated: Jan 10, 2026

    Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors
    09:11

    Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

    Published on: November 23, 2019

    7.1K
    Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
    10:33

    Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

    Published on: October 26, 2015

    11.8K
    Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
    08:49

    Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

    Published on: January 22, 2019

    9.5K

    Area of Science:

    • Biochemistry
    • Structural Biology
    • Medicinal Chemistry

    Background:

    • Inositol polyphosphate multikinase (IPMK) is implicated in various cancers.
    • Targeting IPMK with ATP-competitive inhibitors shows promise.
    • The structural basis for inhibitor potency remains unclear.

    Purpose of the Study:

    • To elucidate the structural mechanisms underlying the high potency of IPMK inhibitors.
    • To provide a structural reference for future IPMK inhibitor design.

    Main Methods:

    • Co-crystallization of human IPMK kinase domain with 14 novel inhibitors.
    • X-ray crystallography at 1.7Å - 2.0Å resolution.
    • Radiolabeled assays and isothermal titration calorimetry for IC50 and KD determination.

    Main Results:

    • 14 novel co-crystal structures of human IPMK with inhibitors were determined.
    • A specific pocket within the ATP-binding site is crucial for potent inhibitor binding.
    • Ordered water molecules contribute to hydrogen-bonding networks with potent inhibitors.

    Conclusions:

    • The study provides the molecular basis for increased potency and selectivity of IPMK inhibitors.
    • The reported structures serve as a valuable resource for structure-based IPMK inhibitor development.